Quick Answer
Annexon, Inc. reported Research And Development Expense of $184.70 million for the year ending 2025.
- Annexon, Inc. showed an increase of +54.6% in Research And Development Expense from 2024 to 2025.
- This data is from Annexon, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $5.99 million | Q3 2019: $7.09 million | Q1 2020: $10.22 million | Q2 2020: $9.29 million | Q3 2020: $11.78 million | Q1 2021: $20.70 million | Q2 2021: $24.57 million | Q3 2021: $27.58 million | Q1 2022: $27.00 million | Q2 2022: $29.11 million | Q3 2022: $27.86 million | Q1 2023: $32.35 million | Q2 2023: $30.25 million | Q3 2023: $27.89 million | Q1 2024: $20.96 million | Q2 2024: $25.03 million | Q3 2024: $30.11 million | Q1 2025: $48.18 million | Q2 2025: $44.16 million | Q3 2025: $49.70 million.
- Over the full 7 years of available data (2019 to 2025), Annexon, Inc.'s Research And Development Expense has grown by 653.1%.
- Historical annual values: Fiscal year 2025: $184.70 million | Fiscal year 2024: $119.45 million | Fiscal year 2023: $113.76 million | Fiscal year 2022: $112.50 million | Fiscal year 2021: $100.07 million | Fiscal year 2020: $49.27 million | Fiscal year 2019: $24.52 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: